Updates

Nath Bio-Genes has announced a board meeting on the unaudited financial results for Q1 FY26. The company reported 15% revenue growth to ₹2802 Mn, driven by strong volume and value growth in cotton (+16% volume, +21% value) and maize (+5% volume, +24% value). Paddy value rose 9% despite a volume dip, while bajra showed stable volumes with 12% value growth.

EBITDA rose 5% to ₹389 Mn, with margins steady at 14%. The Uzbekistan JV completed its first full year, supporting international expansion.

Focus remains on diversifying beyond cotton, enhancing margins, and driving innovation through R&D.